BRAIN Biotech AG reported earnings results for the full year ended September 30, 2022. For the full year, the company reported sales was EUR 49.51 million compared to EUR 38.39 million a year ago. Revenue was EUR 53.07 million compared to EUR 40.73 million a year ago.

Net loss was EUR 6.59 million compared to EUR 4.97 million a year ago. Basic loss per share from continuing operations was EUR 0.3 compared to EUR 0.25 a year ago. Diluted loss per share from continuing operations was EUR 0.3 compared to EUR 0.25 a year ago.